世界の視神経膠腫市場規模・現状・予測2021-2027

【英語タイトル】Global Optic Nerve Glioma Market Size, Status and Forecast 2021-2027

QYResearchが出版した調査資料(QY21APR4285)・商品コード:QY21APR4285
・発行会社(調査会社):QYResearch
・発行日:2021年4月
・ページ数:96
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥499,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥748,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥998,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査資料では、視神経膠腫の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(神経学的検査、コンピューター断層撮影(CT)、磁気共鳴画像法(MRI)、生検)、用途別市場規模(病院・診療所、診断センター、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・視神経膠腫の市場動向
・企業の競争状況、市場シェア
・視神経膠腫の種類別市場規模(神経学的検査、コンピューター断層撮影(CT)、磁気共鳴画像法(MRI)、生検)
・視神経膠腫の用途別市場規模(病院・診療所、診断センター、その他)
・視神経膠腫の北米市場規模2016-2027(アメリカ、カナダ)
・視神経膠腫の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・視神経膠腫のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・視神経膠腫の中南米市場規模2016-2027(メキシコ、ブラジル)
・視神経膠腫の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Biocompare、Bio-Rad Laboratories、Miltenyi Biotec、BioLegend、Becton, Dickinson And Company、Beckman Coulter、Merck、ImmunoReagents、Thermo Fisher Scientific)
・結論
【レポートの概要】

An optic nerve glioma is a type of brain tumor. There are multiple kinds of brain tumors. Typically, each type of tumor is named after the kinds of cells it affects. Most optic nerve gliomas are considered low-grade and don’t grow as quickly as other types of brain tumors. They are found in the optic chiasm, where the left and right optic nerves cross. They are also referred to as optic glioma or juvenile pilocytic astrocytoma. Optic nerve glioma is a rare kind of cancer that’s typically slow growing and found in children. It is rarely found in individuals over the age of 20. It has also been associated with the genetic disorder neurofibromatosis type 1, or NF1.
Treatment for these cancers is best done by a multidisciplinary treatment team. Surgery and radiation therapy are two possible ways of treating optic nerve glioma. Surgery may be performed if doctors believe they can use it to completely remove the tumor. Alternately, if the tumor is not completely removable, surgeons may remove parts of it to help relieve pressure in the skull. Radiation therapy can be done before surgery to shrink the tumor before doctors it. Alternately, it may be done after surgery to kill any remaining cancer cells. Radiation therapy involves using a machine to aim high-energy rays at the site of the tumor. Chemotherapy uses medications to kill cancer cells. This is particularly useful if the cancer has spread to other parts of the brain. Corticosteroids may be administered to reduce swelling in the skull.

Market Analysis and Insights: Global Optic Nerve Glioma Market
The global Optic Nerve Glioma market size is projected to reach US$ 382.3 million by 2026, from US$ 319.5 million in 2019, at a CAGR of 2.6% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Optic Nerve Glioma market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Optic Nerve Glioma market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Optic Nerve Glioma market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Optic Nerve Glioma market.

Global Optic Nerve Glioma Scope and Market Size
Optic Nerve Glioma market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Optic Nerve Glioma market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Diagnosis and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Diagnosis
Neurological Exam
Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Biopsy

Segment by Application
Hospitals & Clinics
Diagnostic Centers
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Biocompare
Bio-Rad Laboratories
Miltenyi Biotec
BioLegend
Becton, Dickinson And Company
Beckman Coulter
Merck
ImmunoReagents
Thermo Fisher Scientific

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Optic Nerve Glioma Market Size Growth Rate by Diagnosis: 2016 VS 2021 VS 2027
1.2.2 Neurological Exam
1.2.3 Computed Tomography (CT)
1.2.4 Magnetic Resonance Imaging (MRI)
1.2.5 Biopsy
1.3 Market by Application
1.3.1 Global Optic Nerve Glioma Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals & Clinics
1.3.3 Diagnostic Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Optic Nerve Glioma Market Perspective (2016-2027)
2.2 Optic Nerve Glioma Growth Trends by Regions
2.2.1 Optic Nerve Glioma Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Optic Nerve Glioma Historic Market Share by Regions (2016-2021)
2.2.3 Optic Nerve Glioma Forecasted Market Size by Regions (2022-2027)
2.3 Optic Nerve Glioma Industry Dynamic
2.3.1 Optic Nerve Glioma Market Trends
2.3.2 Optic Nerve Glioma Market Drivers
2.3.3 Optic Nerve Glioma Market Challenges
2.3.4 Optic Nerve Glioma Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Optic Nerve Glioma Players by Revenue
3.1.1 Global Top Optic Nerve Glioma Players by Revenue (2016-2021)
3.1.2 Global Optic Nerve Glioma Revenue Market Share by Players (2016-2021)
3.2 Global Optic Nerve Glioma Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Optic Nerve Glioma Revenue
3.4 Global Optic Nerve Glioma Market Concentration Ratio
3.4.1 Global Optic Nerve Glioma Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Optic Nerve Glioma Revenue in 2020
3.5 Optic Nerve Glioma Key Players Head office and Area Served
3.6 Key Players Optic Nerve Glioma Product Solution and Service
3.7 Date of Enter into Optic Nerve Glioma Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Optic Nerve Glioma Breakdown Data by Diagnosis
4.1 Global Optic Nerve Glioma Historic Market Size by Diagnosis (2016-2021)
4.2 Global Optic Nerve Glioma Forecasted Market Size by Diagnosis (2022-2027)

5 Optic Nerve Glioma Breakdown Data by Application
5.1 Global Optic Nerve Glioma Historic Market Size by Application (2016-2021)
5.2 Global Optic Nerve Glioma Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Optic Nerve Glioma Market Size (2016-2027)
6.2 North America Optic Nerve Glioma Market Size by Diagnosis
6.2.1 North America Optic Nerve Glioma Market Size by Diagnosis (2016-2021)
6.2.2 North America Optic Nerve Glioma Market Size by Diagnosis (2022-2027)
6.2.3 North America Optic Nerve Glioma Market Size by Diagnosis (2016-2027)
6.3 North America Optic Nerve Glioma Market Size by Application
6.3.1 North America Optic Nerve Glioma Market Size by Application (2016-2021)
6.3.2 North America Optic Nerve Glioma Market Size by Application (2022-2027)
6.3.3 North America Optic Nerve Glioma Market Size by Application (2016-2027)
6.4 North America Optic Nerve Glioma Market Size by Country
6.4.1 North America Optic Nerve Glioma Market Size by Country (2016-2021)
6.4.2 North America Optic Nerve Glioma Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Optic Nerve Glioma Market Size (2016-2027)
7.2 Europe Optic Nerve Glioma Market Size by Diagnosis
7.2.1 Europe Optic Nerve Glioma Market Size by Diagnosis (2016-2021)
7.2.2 Europe Optic Nerve Glioma Market Size by Diagnosis (2022-2027)
7.2.3 Europe Optic Nerve Glioma Market Size by Diagnosis (2016-2027)
7.3 Europe Optic Nerve Glioma Market Size by Application
7.3.1 Europe Optic Nerve Glioma Market Size by Application (2016-2021)
7.3.2 Europe Optic Nerve Glioma Market Size by Application (2022-2027)
7.3.3 Europe Optic Nerve Glioma Market Size by Application (2016-2027)
7.4 Europe Optic Nerve Glioma Market Size by Country
7.4.1 Europe Optic Nerve Glioma Market Size by Country (2016-2021)
7.4.2 Europe Optic Nerve Glioma Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Optic Nerve Glioma Market Size (2016-2027)
8.2 Asia-Pacific Optic Nerve Glioma Market Size by Diagnosis
8.2.1 Asia-Pacific Optic Nerve Glioma Market Size by Diagnosis (2016-2021)
8.2.2 Asia-Pacific Optic Nerve Glioma Market Size by Diagnosis (2022-2027)
8.2.3 Asia-Pacific Optic Nerve Glioma Market Size by Diagnosis (2016-2027)
8.3 Asia-Pacific Optic Nerve Glioma Market Size by Application
8.3.1 Asia-Pacific Optic Nerve Glioma Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Optic Nerve Glioma Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Optic Nerve Glioma Market Size by Application (2016-2027)
8.4 Asia-Pacific Optic Nerve Glioma Market Size by Region
8.4.1 Asia-Pacific Optic Nerve Glioma Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Optic Nerve Glioma Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Optic Nerve Glioma Market Size (2016-2027)
9.2 Latin America Optic Nerve Glioma Market Size by Diagnosis
9.2.1 Latin America Optic Nerve Glioma Market Size by Diagnosis (2016-2021)
9.2.2 Latin America Optic Nerve Glioma Market Size by Diagnosis (2022-2027)
9.2.3 Latin America Optic Nerve Glioma Market Size by Diagnosis (2016-2027)
9.3 Latin America Optic Nerve Glioma Market Size by Application
9.3.1 Latin America Optic Nerve Glioma Market Size by Application (2016-2021)
9.3.2 Latin America Optic Nerve Glioma Market Size by Application (2022-2027)
9.3.3 Latin America Optic Nerve Glioma Market Size by Application (2016-2027)
9.4 Latin America Optic Nerve Glioma Market Size by Country
9.4.1 Latin America Optic Nerve Glioma Market Size by Country (2016-2021)
9.4.2 Latin America Optic Nerve Glioma Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Optic Nerve Glioma Market Size (2016-2027)
10.2 Middle East & Africa Optic Nerve Glioma Market Size by Diagnosis
10.2.1 Middle East & Africa Optic Nerve Glioma Market Size by Diagnosis (2016-2021)
10.2.2 Middle East & Africa Optic Nerve Glioma Market Size by Diagnosis (2022-2027)
10.2.3 Middle East & Africa Optic Nerve Glioma Market Size by Diagnosis (2016-2027)
10.3 Middle East & Africa Optic Nerve Glioma Market Size by Application
10.3.1 Middle East & Africa Optic Nerve Glioma Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Optic Nerve Glioma Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Optic Nerve Glioma Market Size by Application (2016-2027)
10.4 Middle East & Africa Optic Nerve Glioma Market Size by Country
10.4.1 Middle East & Africa Optic Nerve Glioma Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Optic Nerve Glioma Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Biocompare
11.1.1 Biocompare Company Details
11.1.2 Biocompare Business Overview
11.1.3 Biocompare Optic Nerve Glioma Introduction
11.1.4 Biocompare Revenue in Optic Nerve Glioma Business (2016-2021)
11.1.5 Biocompare Recent Development
11.2 Bio-Rad Laboratories
11.2.1 Bio-Rad Laboratories Company Details
11.2.2 Bio-Rad Laboratories Business Overview
11.2.3 Bio-Rad Laboratories Optic Nerve Glioma Introduction
11.2.4 Bio-Rad Laboratories Revenue in Optic Nerve Glioma Business (2016-2021)
11.2.5 Bio-Rad Laboratories Recent Development
11.3 Miltenyi Biotec
11.3.1 Miltenyi Biotec Company Details
11.3.2 Miltenyi Biotec Business Overview
11.3.3 Miltenyi Biotec Optic Nerve Glioma Introduction
11.3.4 Miltenyi Biotec Revenue in Optic Nerve Glioma Business (2016-2021)
11.3.5 Miltenyi Biotec Recent Development
11.4 BioLegend
11.4.1 BioLegend Company Details
11.4.2 BioLegend Business Overview
11.4.3 BioLegend Optic Nerve Glioma Introduction
11.4.4 BioLegend Revenue in Optic Nerve Glioma Business (2016-2021)
11.4.5 BioLegend Recent Development
11.5 Becton, Dickinson And Company
11.5.1 Becton, Dickinson And Company Company Details
11.5.2 Becton, Dickinson And Company Business Overview
11.5.3 Becton, Dickinson And Company Optic Nerve Glioma Introduction
11.5.4 Becton, Dickinson And Company Revenue in Optic Nerve Glioma Business (2016-2021)
11.5.5 Becton, Dickinson And Company Recent Development
11.6 Beckman Coulter
11.6.1 Beckman Coulter Company Details
11.6.2 Beckman Coulter Business Overview
11.6.3 Beckman Coulter Optic Nerve Glioma Introduction
11.6.4 Beckman Coulter Revenue in Optic Nerve Glioma Business (2016-2021)
11.6.5 Beckman Coulter Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Optic Nerve Glioma Introduction
11.7.4 Merck Revenue in Optic Nerve Glioma Business (2016-2021)
11.7.5 Merck Recent Development
11.8 ImmunoReagents
11.8.1 ImmunoReagents Company Details
11.8.2 ImmunoReagents Business Overview
11.8.3 ImmunoReagents Optic Nerve Glioma Introduction
11.8.4 ImmunoReagents Revenue in Optic Nerve Glioma Business (2016-2021)
11.8.5 ImmunoReagents Recent Development
11.9 Thermo Fisher Scientific
11.9.1 Thermo Fisher Scientific Company Details
11.9.2 Thermo Fisher Scientific Business Overview
11.9.3 Thermo Fisher Scientific Optic Nerve Glioma Introduction
11.9.4 Thermo Fisher Scientific Revenue in Optic Nerve Glioma Business (2016-2021)
11.9.5 Thermo Fisher Scientific Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Optic Nerve Glioma Market Size Growth Rate by Diagnosis (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Neurological Exam
Table 3. Key Players of Computed Tomography (CT)
Table 4. Key Players of Magnetic Resonance Imaging (MRI)
Table 5. Key Players of Biopsy
Table 6. Global Optic Nerve Glioma Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Optic Nerve Glioma Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Optic Nerve Glioma Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Optic Nerve Glioma Market Share by Regions (2016-2021)
Table 10. Global Optic Nerve Glioma Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Optic Nerve Glioma Market Share by Regions (2022-2027)
Table 12. Optic Nerve Glioma Market Trends
Table 13. Optic Nerve Glioma Market Drivers
Table 14. Optic Nerve Glioma Market Challenges
Table 15. Optic Nerve Glioma Market Restraints
Table 16. Global Optic Nerve Glioma Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Optic Nerve Glioma Market Share by Players (2016-2021)
Table 18. Global Top Optic Nerve Glioma Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Optic Nerve Glioma as of 2020)
Table 19. Ranking of Global Top Optic Nerve Glioma Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Optic Nerve Glioma Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Optic Nerve Glioma Product Solution and Service
Table 23. Date of Enter into Optic Nerve Glioma Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Optic Nerve Glioma Market Size by Diagnosis (2016-2021) (US$ Million)
Table 26. Global Optic Nerve Glioma Revenue Market Share by Diagnosis (2016-2021)
Table 27. Global Optic Nerve Glioma Forecasted Market Size by Diagnosis (2022-2027) (US$ Million)
Table 28. Global Optic Nerve Glioma Revenue Market Share by Diagnosis (2022-2027) & (US$ Million)
Table 29. Global Optic Nerve Glioma Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Optic Nerve Glioma Revenue Market Share by Application (2016-2021)
Table 31. Global Optic Nerve Glioma Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Optic Nerve Glioma Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Optic Nerve Glioma Market Size by Diagnosis (2016-2021) (US$ Million)
Table 34. North America Optic Nerve Glioma Market Size by Diagnosis (2022-2027) & (US$ Million)
Table 35. North America Optic Nerve Glioma Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Optic Nerve Glioma Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Optic Nerve Glioma Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Optic Nerve Glioma Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Optic Nerve Glioma Market Size by Diagnosis (2016-2021) (US$ Million)
Table 40. Europe Optic Nerve Glioma Market Size by Diagnosis (2022-2027) & (US$ Million)
Table 41. Europe Optic Nerve Glioma Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Optic Nerve Glioma Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Optic Nerve Glioma Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Optic Nerve Glioma Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Optic Nerve Glioma Market Size by Diagnosis (2016-2021) (US$ Million)
Table 46. Asia-Pacific Optic Nerve Glioma Market Size by Diagnosis (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Optic Nerve Glioma Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Optic Nerve Glioma Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Optic Nerve Glioma Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Optic Nerve Glioma Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Optic Nerve Glioma Market Size by Diagnosis (2016-2021) (US$ Million)
Table 52. Latin America Optic Nerve Glioma Market Size by Diagnosis (2022-2027) & (US$ Million)
Table 53. Latin America Optic Nerve Glioma Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Optic Nerve Glioma Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Optic Nerve Glioma Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Optic Nerve Glioma Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Optic Nerve Glioma Market Size by Diagnosis (2016-2021) (US$ Million)
Table 58. Middle East & Africa Optic Nerve Glioma Market Size by Diagnosis (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Optic Nerve Glioma Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Optic Nerve Glioma Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Optic Nerve Glioma Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Optic Nerve Glioma Market Size by Country (2022-2027) & (US$ Million)
Table 63. Biocompare Company Details
Table 64. Biocompare Business Overview
Table 65. Biocompare Optic Nerve Glioma Product
Table 66. Biocompare Revenue in Optic Nerve Glioma Business (2016-2021) & (US$ Million)
Table 67. Biocompare Recent Development
Table 68. Bio-Rad Laboratories Company Details
Table 69. Bio-Rad Laboratories Business Overview
Table 70. Bio-Rad Laboratories Optic Nerve Glioma Product
Table 71. Bio-Rad Laboratories Revenue in Optic Nerve Glioma Business (2016-2021) & (US$ Million)
Table 72. Bio-Rad Laboratories Recent Development
Table 73. Miltenyi Biotec Company Details
Table 74. Miltenyi Biotec Business Overview
Table 75. Miltenyi Biotec Optic Nerve Glioma Product
Table 76. Miltenyi Biotec Revenue in Optic Nerve Glioma Business (2016-2021) & (US$ Million)
Table 77. Miltenyi Biotec Recent Development
Table 78. BioLegend Company Details
Table 79. BioLegend Business Overview
Table 80. BioLegend Optic Nerve Glioma Product
Table 81. BioLegend Revenue in Optic Nerve Glioma Business (2016-2021) & (US$ Million)
Table 82. BioLegend Recent Development
Table 83. Becton, Dickinson And Company Company Details
Table 84. Becton, Dickinson And Company Business Overview
Table 85. Becton, Dickinson And Company Optic Nerve Glioma Product
Table 86. Becton, Dickinson And Company Revenue in Optic Nerve Glioma Business (2016-2021) & (US$ Million)
Table 87. Becton, Dickinson And Company Recent Development
Table 88. Beckman Coulter Company Details
Table 89. Beckman Coulter Business Overview
Table 90. Beckman Coulter Optic Nerve Glioma Product
Table 91. Beckman Coulter Revenue in Optic Nerve Glioma Business (2016-2021) & (US$ Million)
Table 92. Beckman Coulter Recent Development
Table 93. Merck Company Details
Table 94. Merck Business Overview
Table 95. Merck Optic Nerve Glioma Product
Table 96. Merck Revenue in Optic Nerve Glioma Business (2016-2021) & (US$ Million)
Table 97. Merck Recent Development
Table 98. ImmunoReagents Company Details
Table 99. ImmunoReagents Business Overview
Table 100. ImmunoReagents Revenue in Optic Nerve Glioma Business (2016-2021) & (US$ Million)
Table 101. ImmunoReagents Recent Development
Table 102. Thermo Fisher Scientific Company Details
Table 103. Thermo Fisher Scientific Business Overview
Table 104. Thermo Fisher Scientific Optic Nerve Glioma Product
Table 105. Thermo Fisher Scientific Revenue in Optic Nerve Glioma Business (2016-2021) & (US$ Million)
Table 106. Thermo Fisher Scientific Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Optic Nerve Glioma Market Share by Diagnosis: 2020 VS 2027
Figure 2. Neurological Exam Features
Figure 3. Computed Tomography (CT) Features
Figure 4. Magnetic Resonance Imaging (MRI) Features
Figure 5. Biopsy Features
Figure 6. Global Optic Nerve Glioma Market Share by Application: 2020 VS 2027
Figure 7. Hospitals & Clinics Case Studies
Figure 8. Diagnostic Centers Case Studies
Figure 9. Others Case Studies
Figure 10. Optic Nerve Glioma Report Years Considered
Figure 11. Global Optic Nerve Glioma Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Optic Nerve Glioma Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Optic Nerve Glioma Market Share by Regions: 2020 VS 2027
Figure 14. Global Optic Nerve Glioma Market Share by Regions (2022-2027)
Figure 15. Global Optic Nerve Glioma Market Share by Players in 2020
Figure 16. Global Top Optic Nerve Glioma Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Optic Nerve Glioma as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Optic Nerve Glioma Revenue in 2020
Figure 18. Global Optic Nerve Glioma Revenue Market Share by Diagnosis (2016-2021)
Figure 19. Global Optic Nerve Glioma Revenue Market Share by Diagnosis (2022-2027)
Figure 20. North America Optic Nerve Glioma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Optic Nerve Glioma Market Share by Diagnosis (2016-2027)
Figure 22. North America Optic Nerve Glioma Market Share by Application (2016-2027)
Figure 23. North America Optic Nerve Glioma Market Share by Country (2016-2027)
Figure 24. United States Optic Nerve Glioma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Optic Nerve Glioma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Optic Nerve Glioma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Optic Nerve Glioma Market Share by Diagnosis (2016-2027)
Figure 28. Europe Optic Nerve Glioma Market Share by Application (2016-2027)
Figure 29. Europe Optic Nerve Glioma Market Share by Country (2016-2027)
Figure 30. Germany Optic Nerve Glioma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Optic Nerve Glioma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Optic Nerve Glioma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Optic Nerve Glioma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Optic Nerve Glioma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Optic Nerve Glioma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Optic Nerve Glioma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Optic Nerve Glioma Market Share by Diagnosis (2016-2027)
Figure 38. Asia-Pacific Optic Nerve Glioma Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Optic Nerve Glioma Market Share by Region (2016-2027)
Figure 40. China Optic Nerve Glioma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Optic Nerve Glioma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Optic Nerve Glioma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Optic Nerve Glioma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Optic Nerve Glioma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Optic Nerve Glioma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Optic Nerve Glioma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Optic Nerve Glioma Market Share by Diagnosis (2016-2027)
Figure 48. Latin America Optic Nerve Glioma Market Share by Application (2016-2027)
Figure 49. Latin America Optic Nerve Glioma Market Share by Country (2016-2027)
Figure 50. Mexico Optic Nerve Glioma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Optic Nerve Glioma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Optic Nerve Glioma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Optic Nerve Glioma Market Share by Diagnosis (2016-2027)
Figure 54. Middle East & Africa Optic Nerve Glioma Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Optic Nerve Glioma Market Share by Country (2016-2027)
Figure 56. Turkey Optic Nerve Glioma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Optic Nerve Glioma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Optic Nerve Glioma Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Biocompare Revenue Growth Rate in Optic Nerve Glioma Business (2016-2021)
Figure 60. Bio-Rad Laboratories Revenue Growth Rate in Optic Nerve Glioma Business (2016-2021)
Figure 61. Miltenyi Biotec Revenue Growth Rate in Optic Nerve Glioma Business (2016-2021)
Figure 62. BioLegend Revenue Growth Rate in Optic Nerve Glioma Business (2016-2021)
Figure 63. Becton, Dickinson And Company Revenue Growth Rate in Optic Nerve Glioma Business (2016-2021)
Figure 64. Beckman Coulter Revenue Growth Rate in Optic Nerve Glioma Business (2016-2021)
Figure 65. Merck Revenue Growth Rate in Optic Nerve Glioma Business (2016-2021)
Figure 66. ImmunoReagents Revenue Growth Rate in Optic Nerve Glioma Business (2016-2021)
Figure 67. Thermo Fisher Scientific Revenue Growth Rate in Optic Nerve Glioma Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed


【掲載企業】

Biocompare、Bio-Rad Laboratories、Miltenyi Biotec、BioLegend、Becton, Dickinson And Company、Beckman Coulter、Merck、ImmunoReagents、Thermo Fisher Scientific

★調査レポート[世界の視神経膠腫市場規模・現状・予測2021-2027] (コード:QY21APR4285)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の視神経膠腫市場規模・現状・予測2021-2027]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆